Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

8224	Companies
110996	Keywords
52729	Articles
60922	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

PRESS RELEASE

published on 04/08/2024 at 07:00, 7 months ago

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
Newron Pharmaceuticals presented data from study 014/015 and evenamide clinical development outlook at SIRS 2024 Congress, showcasing potential for new TRS treatment options

Clinical Development Newron Pharmaceuticals Evenamide Study 014/015 Schizophrenia International Research Society
BRIEF

published on 03/19/2024 at 07:05, 7 months 20 days ago

Newron Pharmaceuticals S.p.A. Announces 2023 Financial Results and Provides Outlook for 2024

2024 Outlook Financial Results 2023 Newron Pharmaceuticals Evenamide Development Xadago Safinamide
BRIEF

published on 03/19/2024 at 07:05, 7 months 20 days ago

Newron Pharmaceuticals SpA annonce ses résultats financiers pour 2023 et fournit des perspectives pour 2024

Perspectives 2024 Résultats Financiers 2023 Produits Pharmaceutiques Newron Xadago Safinamide Développement D'Evenamide
PRESS RELEASE

published on 03/19/2024 at 07:00, 7 months 20 days ago

Newron presents 2023 financial results and provides 2024 outlook
Newron Pharmaceuticals S.p.A. presents 2023 financial results and 2024 outlook, including advancements in schizophrenia treatment and strategic partnerships

Financial Results 2024 Outlook Partnerships Newron Pharmaceuticals Schizophrenia Treatment
BRIEF

published on 03/15/2024 at 07:05, 7 months 24 days ago

Newron Pharmaceuticals SpA annonce un accord de remboursement modifié avec la Banque européenne d'investissement

Produits Pharmaceutiques Newron Evenamide Banque Européenne D'investissement Accord De Financement Traitements Du SNC
BRIEF

published on 03/15/2024 at 07:05, 7 months 24 days ago

Newron Pharmaceuticals S.p.A. Announces Amended Repayment Agreement with European Investment Bank

European Investment Bank Newron Pharmaceuticals Financing Agreement Evenamide CNS Treatments
PRESS RELEASE

published on 03/15/2024 at 07:00, 7 months 24 days ago

Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
Newron Pharmaceuticals S.p.A. agrees with EIB to extend repayment dates of 2018 financing agreement tranches after pipeline milestones

European Investment Bank Financing Agreement Evenamide Newron Pharmaceuticals S.p.A. Loan Repayment Dates
BRIEF

published on 03/14/2024 at 18:37, 7 months 24 days ago

Newron Pharmaceuticals obtient jusqu'à 15 millions d'euros de financement grâce à l'émission de nouvelles actions

Émission D'actions Produits Biopharmaceutiques Accord D'investissement Produits Pharmaceutiques Newron Thérapies Du SNC
BRIEF

published on 03/14/2024 at 18:37, 7 months 24 days ago

Newron Pharmaceuticals Secures Up to EUR 15 Million in Funding Through New Share Issuance

Share Issuance Biopharmaceuticals Investment Agreement Newron Pharmaceuticals CNS Therapies
PRESS RELEASE

published on 03/14/2024 at 18:32, 7 months 24 days ago

Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million
Newron Pharmaceuticals S.p.A. enters a subscription agreement for up to 2.05 million new shares, aiming to raise EUR 15.0 million. The investment supports CNS therapies development

Subscription Agreement Newron Pharmaceuticals Newly Issued Shares EUR 15.0 Million CNS Therapies Development

Accesswire

Published on 11/08/2024 at 10:00, 25 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 1 hour 25 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 3 hours 25 minutes ago

Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 7 hours 25 minutes ago

Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 01:25, 9 hours ago

PetroFrontier Corp. Announces Execution of Definitive Agreements for $15.1 Million Funding Arrangement

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 10:15, 10 minutes ago

Singapore - A Trusted Global Supply Chain Management Hub
Published on 11/08/2024 at 10:14, 11 minutes ago

Turkiye Garanti Bankasi A.S.: Board Of Directors Decision About Issuing Covered Bonds to be sold domestically and Authorization of Head Office for Necessary Operations
Published on 11/08/2024 at 10:10, 15 minutes ago

Turkiye Garanti Bankasi A.S.: Authorization for the issuance of Mortgage-Covered Bonds
Published on 11/08/2024 at 10:00, 24 minutes ago

Dalata Hotel Group plc announces completion of the sale of Maldron Hotel Wexford
Published on 11/08/2024 at 09:44, 40 minutes ago

OPPO Celebrates Global Photography Talent at Paris Photo Fair under the theme of 'Dear Life'

Les Echos

Published on 11/08/2024 at 08:00, 2 hours 25 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 15 hours 25 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 15 hours 25 minutes ago

ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 15 hours 25 minutes ago

ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 15 hours 25 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE